Absci and AMD Announce Collaboration and Strategic Investment …
4 days ago · “Absci’s groundbreaking work in AI drug discovery is a perfect fit for AMD high-performance computing solutions and software, designed for the most demanding AI workloads.” About Absci Absci is a data-first generative AI drug creation company that combines AI with scalable wet lab technologies to create better biologics for patients, faster.
Absci Corporation (ABSI) Latest Stock News & Headlines
Get the latest Absci Corporation (ABSI) stock news and headlines to help you in your trading and investing decisions.
Absci and Owkin Synergize Leading TechBio Platforms to Advance ...
1 day ago · VANCOUVER, Wash. and PARIS, Jan. 10, 2025 (GLOBE NEWSWIRE) -- Absci Corporation (NASDAQ: ABSI), a data-first generative AI drug creation company, and Owkin, a TechBio that uses agentic AI to ...
Absci Shares Rise 27% on Report of $20 Mln Investment
Shares of Absci on Wednesday jumped following a report on a $20 million investment from Advanced Micro Devices. ... Dow Jones Newswires is a market-moving financial and business news source, used ...
Absci and Invetx Partner to Bring Generative AI Drug Creation …
5 days ago · VANCOUVER, Wash. and BOSTON, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Absci Corporation (NASDAQ: ABSI), a data-first generative AI drug creation company, and Invetx, a pioneer in protein-based ...
Press Releases - Absci
Absci Announces Collaboration with AstraZeneca to Advance AI-Driven Oncology Candidate Almirall and Absci Announce AI Drug Discovery Partnership to Rapidly Develop Novel Treatments for Dermatological Diseases
Absci Corporation (ABSI) Latest Stock News - Seeking Alpha
Get the latest news and real-time alerts from Absci Corporation (ABSI) stock at Seeking Alpha.
AMD invests $20 million in AI drug research at Vancouver-based Absci
3 days ago · The investment sent Absci shares up nearly 5% Wednesday, to $3.22. The companies didn’t disclose the price AMD is paying for shares in the Vancouver company. Absci employs about 160, including ...
Absci, Invetx partner to bring AI drug creation platform to animal ...
6 days ago · Absci and Invetx announced a strategic partnership to harness Absci’s AI Drug Creation models to create an innovative Half-Life Extension, HLE, platform for animal health applications.Under the ...
Absci, AMD announce collaboration, strategic investment
3 days ago · Absci Corporation (ABSI) announced a strategic collaboration with AMD (AMD) to deploy AMD Instinct accelerators and ROCm software to power critical AI drug discovery workloads, including Absci’s ...